EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Eugenol nanoparticle as a therapeutic agent against Pseudomonas infection in mice

Sourav Ghosh, Tarakdas Basu iD

Pathogens and Disease · 2025

DOI: 10.1093/femspd/ftaf014 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pathogens and Disease, 2025. Verfasst von Sourav Ghosh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Biophysics, University of Kalyani, Kalyani 741235, West Bengal, India. Hauptthemen laut MEDLINE: Eugenol, Pseudomonas Infections, Nanoparticles, Anti-Bacterial Agents. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: UGC-DAE Consortium for Scientific Research, University Grants Commission.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We reported earlier about development of nano-formulation of an essential oil “eugenol” through its entrapment within animal protein “gelatin,” using a simple ultrasonication technique, followed by purification via ultracentrifugation. The synthesized eugenol nanoparticle (ENP) exhibited promising antibacterial and antibiofilm activity on pathogenic strain Pseudomonas aeruginosa MTCC 2488 in vitro. Here, we report on in vivo therapeutic efficacy of ENP against Pseudomonas-administered lung infection, developed in BALB/c mice. Our findings revealed that ENP treatment significantly reduced bacterial burden in infected lung tissues and promoted recovery from infection-associated weight loss, hypothermia, and fluid accumulation in mice. In addition, histopathological and immunological studies showed that the elevated level of inflammatory cytokines TNF-α, IL-1β, MCP-1, GM-CSF, and IFN-γ in lung tissue, serum, and broncho-alveolar lavage (BAL) fluid of Pseudomonas-infected mice were considerably attenuated to almost normal level by ENP treatment. Notably, free eugenol had not so high antipseudomonal action as ENP.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EugenolPseudomonas InfectionsNanoparticlesAnti-Bacterial AgentsPseudomonas aeruginosaAnimalsMice, Inbred BALB CLungMiceDisease Models, AnimalCytokinesTreatment OutcomeFemaleBacterial LoadBronchoalveolar Lavage Fluid

Stichwörter der Autor:innen

P. aeruginosaBALB/c miceeugenollung infectionnanonization

Substanzen

EugenolAnti-Bacterial AgentsCytokines

Autor:innen und Institutionen

  • Department of Biochemistry and Biophysics, University of Kalyani, Kalyani 741235, West Bengal, India.

ORCID-Profile: Tarakdas Basu

Förderung

  • UGC-DAE Consortium for Scientific Research, University Grants Commission

Zitieren

APA

Ghosh, S., & Basu, T. (2025). Eugenol nanoparticle as a therapeutic agent against Pseudomonas infection in mice. Pathogens and Disease. https://doi.org/10.1093/femspd/ftaf014

Vancouver

Ghosh S, Basu T. Eugenol nanoparticle as a therapeutic agent against Pseudomonas infection in mice. Pathogens and Disease. 2025. doi:10.1093/femspd/ftaf014

BibTeX
@article{Ghosh2025,
  author = {Ghosh, Sourav and Basu, Tarakdas},
  title = {Eugenol nanoparticle as a therapeutic agent against Pseudomonas infection in mice},
  journal = {Pathogens and Disease},
  year = {2025},
  doi = {10.1093/femspd/ftaf014}
}
Kostenlos starten →